Once-weekly basal insulin is an option for selected adults with type 2 diabetes. Awiqli and Onswik are different products with different concentrations and transition schedules.
Discover Nao Medical's virtual care solutions for occupational health. From wellness checkups to mental health support, boost productivity with care from anywhere.
Once-weekly basal insulin is an option for selected adults with type 2 diabetes. Awiqli and Onswik are different products with different concentrations and transition schedules. A supervised switch is essential.
The current US labels are for adult type 2 diabetes. Onswik is not recommended for type 1 diabetes because of severe low-glucose risk. Weekly treatment requires reliable monitoring and an ability to follow a product-specific weekly schedule.
Review current basal and mealtime insulin, glucose patterns, kidney function, and low-glucose history. Confirm access before changing treatment. The prescriber sets the initial and later doses, timing, and monitoring plan. Teach the exact pen and a written weekly record. Never calculate a conversion by multiplying the daily dose by seven yourself.
Bring insulin labels and devices, the exact daily regimen, meter or CGM report, kidney tests, and a record of lows. Describe work shifts, illness, or missed doses.
Do not use a concentrated pen as though it were another insulin. Never withdraw insulin from the pen into a syringe. Severe low glucose, accidental extra doses, or acute illness needs urgent advice. Keep existing insulin while awaiting a supervised switch.
Monitor more closely during a transition or dose change. Report lows promptly and keep a clear dose record. If the day or dose is uncertain, contact the clinician before another injection. A weekly schedule does not eliminate regular diabetes review.
Confirm the exact service, clinician, formulation, appointment, and refill route before booking. The evaluation, tests, medicine, administration, and follow-up may have separate costs and benefits. Ask for current estimates and required records. An FDA-approved drug or a clinic address does not establish pharmacy stock, onsite treatment, coverage, or a prescription. If access changes, contact the treating team before interrupting treatment.
No. Insurance payment for the consultation does not guarantee payment for the medicine, testing or administration. Confirm the exact product and indication with the plan, including authorization, benefit rules and expected cost. Ask the clinic which services it provides and how each part of care will be billed.
Ask for separate current estimates for the evaluation, required tests, medicine, administration when relevant, and follow-up. Drug costs depend on product, dose, coverage, pharmacy, and savings eligibility. Self-pay still requires clinical review and monitoring. Confirm any manufacturer program’s current terms directly; a posted price does not guarantee your final cost.
Approval cannot be guaranteed. The plan reviews the exact treatment, indication and submitted records against its rules. Bring any denial or information request so the clinician can address the stated reason. Confirm the actual decision and remaining costs before relying on authorization as a treatment start.
A weekly basal insulin may be self-injected after appropriate training when the prescription and care arrangement allow it. Confirm who teaches the exact pen and reviews glucose. Weekly dosing does not mean that no follow-up is needed.
Choose care according to the problem and how urgently you need help. Urgent care assesses non-emergency illnesses and minor injuries.
